Meeting

Meeting 1: Prevention of HIV Infection among Injecting Drug Users in High Risk Countries


When: December 19, 2005 - December 20, 2005 (8:00 AM Eastern)

Topics Diseases, Global Health, Public Health, Substance Use and Mental Health
Activity: Prevention of HIV Infection among Injecting Drug Users in High Risk Countries
Board: Board on Global Health

 

OPEN SESSION

9:00 - 9:15 a.m.            Welcome, Introductions, and Opening Statement

Hugh Tilson, M.D., Dr.PH.
Committee Chair

9:15 - 9:45 a.m.            Charge to the committee

Peter Piot, M.D., Ph.D.
Executive Director, UNAIDS
Under Secretary-General of the United Nations

9:45 - 10:15a.m.           Overview of addiction

Michael Farrell, MRCPsych              
Reader in Addiction Psychiatry, National Addiction Centre
Institute of Psychiatry
King's College, London                                              

10:15 - 11:00 a.m.        Epidemiology of HIV/AIDS among IDUs in High-Risk Countries and the Global Response

Dr. Peter Ghys        
Acting Associate Director, Epidemic Monitoring and Prevention, Department of Policy, Evidence and Partnerships
UNAIDS 

Catherine Anita Hankins, MD, MSc, FRCPC          
Associate Director of Policy, Evidence and Partnerships
Chief Scientific Adviser
UNAIDS 

11:00 - 11:15 a.m.        Break

11:15a.m. - 12:45 pm Evidence regarding HIV Prevention for IDUs

Overview:

Gerry V. Stimson PhD         
Emeritus Professor, Imperial College London, and
Executive Director, International Harm Reduction Association

Review of needle and syringe exchange programs:        

Dr. Alex Wodak FRACP, FChAM         
Director, Alcohol and Drug Service
St. Vincent's Hospital, Darlinghurst
Australia               

Review of needle and syringe exchange programs:        

Kerstin Kall, MD, Ph.D.
Clinic for Dependency Disorders
University Hospital
Linkoping, Sweden      

Review of drug treatment strategies:

Michael Farrell, MRCPsych          
Reader in Addiction Psychiatry, National Addiction Centre, Institute of Psychiatry
King's College, London       

12:45 - 1:45 p.m.          Lunch

1:45 - 3:15p.m.           Country Perspectives Panel – Asian and Pacific countries

Fujie Zhang, M.D.
Director, Division of Treatment and Care
National Center for AIDS-STD Control and Prevention
Chinese Center for Disease of Control and Prevention

Adeeba Kamarulzaman, MBBS, FRACP
Head, Infectious Diseases Unit
Department of Medicine
University of Malaya Medical Centre
Malaysia
     
Chris Beyrer, MD, MPH
Associate Professor, Department of Epidemiology
Director, Johns Hopkins Fogarty AIDS International Training and Research Program
Director, Johns Hopkins Center for Public Health & Human Rights
Johns Hopkins Bloomberg School of Public Health
(discussing Thailand)

3:15 - 3:30p.m.           Break

3:30 -  5:45 p.m.           Country Perspectives Panel–Former Soviet States, Central and Eastern European countries

Saulius Caplinskas, M.D., Ph.D. 
Director, Lithuanian AIDS Centre
Associate Professor, Mykolas Romeris University       

Monica Ciupagea M.D.
Program Officer
International Harm Reduction Development Program
Open Society Institute, Budapest                                                                                  

Dr. Oleg Tchestnov
Deputy Director of the International Department
Ministry of Health, Russia

Ksenia Eroshina, MPH, Ph.D.
Head of Monitoring & Evaluation Department
Open Health Institute, Moscow, Russia                                                                       

Alexey Mazus M.D. 
Head of Moscow AIDS Center

Inga Upmace, M.D.
Deputy Director,  AIDS Prevention Center, Latvia
Steering Commitee member of CEE-HRN (Central and Eastern Europe Harm Reduction Network) 

Lily Hyde
Harm reduction and IEC Consultant
International HIV/AIDS Alliance in Ukraine

6:30 p.m.     Reception for all meeting participants at the ILO building, hosted by UNAIDS

December 20th

OPEN SESSION

8:30 - 10:00 a.m.          Lessons Learned– Experiences in the U.S., Canada, Australia, and Western European countries

Don C. Des Jarlais, Ph.D.
Director of Research, Baron Edmond de Rothschild Chemical Dependency Institute,
Beth Israel Medical Center
Professor of Epidemiology, Department of Epidemiology and Population Health
Albert Einstein College of Medicine, New York  
      
Dr. Alex Wodak FRACP, FChAM  
Director, Alcohol and Drug Service
St. Vincent's Hospital, Darlinghurst
Australia    

Roel A. Coutinho, M.D., Ph.D. 
Director, Centre for Infectious Disease Control
National Institute for Health and the Environment
The Netherlands 

Gerry V. Stimson PhD 
Emeritus Professor, Imperial College London, and
Executive Director, International Harm Reduction Association   

10:00a.m. - 10:15a.m.      Break

10:15a.m. - 12:30p.m.    Illicit drug policies and the HIV epidemic

Andrew Ball MB BS, FAChAM  
Senior Strategy and Operations Advisor
Department of HIV/AIDS
World Health Organization 

Mr. Christian Kroll          
Senior Coordinator, HIV/AIDS Unit
Global Coordinator on HIV/AIDS
UNODC

Chris Beyrer, MD, MPH 
Associate Professor, Department of Epidemiology
Director, Johns Hopkins Fogarty AIDS International Training and Research Program
Director, Johns Hopkins Center for Public Health & Human Rights
Johns Hopkins Bloomberg School of Public Health 

Mr. Tomas Hallberg
Director, European Cities against Drugs (ECAD)
Stockholm, Sweden

Mr. George Zazulin 
St. Petersburg Regional Director, ECAD, Russia

Dr. Alex Wodak FRACP, FChAM 
Director, Alcohol and Drug Service
St. Vincent's Hospital, Darlinghurst
Australia

Ms. Raminta Stuikyte  
Director, Central and Eastern European Harm Reduction Network

12:30 - 1:30 p.m.        Lunch

1:30 - 2:30pm Community Perspectives

Mr. Loon Gangte (unable to attend)
President, Delhi Network of Positive People, India
Regional Coordinator for South Asia
Collaborative Fund for HIV treatment Preparedness

Mr. Samuel Nugraha  
Partnership and Network Assistant
UNAIDS Secretariat Indonesia 

2:30 - 3:00 p.m.          Methodological considerations in evaluating evidence

Don C. Des Jarlais, Ph.D.  
Director of Research, Baron Edmond de Rothschild Chemical Dependency Institute,
Beth Israel Medical Center
Professor of Epidemiology, Department of Epidemiology and Population Health
Albert Einstein College of Medicine, New York    

3:00 - 3:30 p.m.           Public comments

3:30 p.m.                     Adjourn open session

 

Also of Interest